These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 7632688)

  • 1. Na,K-ATPase inhibitors from bovine hypothalamus and human plasma are different from ouabain: nanogram scale CD structural analysis.
    Zhao N; Lo LC; Berova N; Nakanishi K; Tymiak AA; Ludens JH; Haupert GT
    Biochemistry; 1995 Aug; 34(31):9893-6. PubMed ID: 7632688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypoxia triggers release of an endogenous inhibitor of Na(+)-K(+)-ATPase from midbrain and adrenal.
    De Angelis C; Haupert GT
    Am J Physiol; 1998 Jan; 274(1):F182-8. PubMed ID: 9458838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A non-ouabain Na/K ATPase inhibitor isolated from bovine hypothalamus. Its relation to hypothalamic ouabain.
    Sancho JM
    Clin Exp Hypertens; 1998; 20(5-6):535-42. PubMed ID: 9682909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypothalamic factor inhibits the (Na,K)ATPase from the extracellular surface. Mechanism of inhibition.
    Carilli CT; Berne M; Cantley LC; Haupert GT
    J Biol Chem; 1985 Jan; 260(2):1027-31. PubMed ID: 2981828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physicochemical characterization of a ouabain isomer isolated from bovine hypothalamus.
    Tymiak AA; Norman JA; Bolgar M; DiDonato GC; Lee H; Parker WL; Lo LC; Berova N; Nakanishi K; Haber E
    Proc Natl Acad Sci U S A; 1993 Sep; 90(17):8189-93. PubMed ID: 8396262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endogenous "ouabain-like" activity in bovine plasma.
    Tal DM; Katchalsky S; Lichtstein D; Karlish SJ
    Biochem Biophys Res Commun; 1986 Feb; 135(1):1-8. PubMed ID: 3006675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Digitalis-like activity in human plasma. Purification, affinity, and mechanism.
    Hamlyn JM; Harris DW; Ludens JH
    J Biol Chem; 1989 May; 264(13):7395-404. PubMed ID: 2540192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics of a ouabain-like factor from Milan hypertensive rats.
    Ferrandi M; Minotti E; Salardi S; Florio M; Bianchi G; Ferrari P
    J Cardiovasc Pharmacol; 1993; 22 Suppl 2():S75-8. PubMed ID: 7508036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positive inotropic effects of the endogenous Na+/K(+)-transporting ATPase inhibitor from the hypothalamus.
    Hallaq HA; Haupert GT
    Proc Natl Acad Sci U S A; 1989 Dec; 86(24):10080-4. PubMed ID: 2557617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of hypothalamic Na,K-ATPase inhibitor with isolated human peripheral blood mononuclear cells.
    Anner BM; Lacotte D; Anner RM; Moosmayer M
    Biosci Rep; 1994 Oct; 14(5):231-42. PubMed ID: 7772716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of Na+/K+-ATPase inhibitors in bovine plasma as fatty acids and hydrocarbons.
    Tal DM; Yanuck MD; van Hall G; Karlish SJ
    Biochim Biophys Acta; 1989 Oct; 985(1):55-9. PubMed ID: 2551389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Summary of a symposium on natriuretic and digitalis-like factors.
    Buckalew VM; Gonick HC
    Clin Exp Hypertens; 1998; 20(5-6):481-8. PubMed ID: 9682904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Secretion of a lactone-hydrogenated ouabain-like effector of sodium, potassium-adenosine triphosphatase activity by adrenal cells.
    Qazzaz HM; El-Masri MA; Valdes R
    Endocrinology; 2000 Sep; 141(9):3200-9. PubMed ID: 10965891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a model cardiac glycoside receptor: comparisons with Na+,K+-ATPase.
    Kasturi R; Yuan J; McLean LR; Margolies MN; Ball WJ
    Biochemistry; 1998 May; 37(19):6658-66. PubMed ID: 9578549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of digitalis-like factors in human plasma. Interactions with NaK-ATPase and cross-reactivity with cardiac glycoside-specific antibodies.
    Kelly RA; O'Hara DS; Canessa ML; Mitch WE; Smith TW
    J Biol Chem; 1985 Sep; 260(21):11396-405. PubMed ID: 2995332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bovine adrenals contain, in addition to ouabain, a second inhibitor of the sodium pump.
    Schneider R; Wray V; Nimtz M; Lehmann WD; Kirch U; Antolovic R; Schoner W
    J Biol Chem; 1998 Jan; 273(2):784-92. PubMed ID: 9422732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Properties of the purified hypothalamic pituitary NA/K-ATPase inhibitor.
    Sancho JM; Garcia-Martin E; Garcia-Robles R; Santirso R; Villa E; Gutierrez-Merino C; Ricote M
    J Cardiovasc Pharmacol; 1993; 22 Suppl 2():S32-4. PubMed ID: 7508022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ischemia-induced enhancement of digitalis sensitivity in isolated guinea-pig heart.
    Kim DH; Akera T; Kennedy RH
    J Pharmacol Exp Ther; 1983 Aug; 226(2):335-42. PubMed ID: 6308206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation and characterization of a specific endogenous Na+,K+-ATPase inhibitor from bovine adrenal.
    Tamura M; Lam TT; Inagami T
    Biochemistry; 1988 Jun; 27(12):4244-53. PubMed ID: 2844224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypothalamic Na(+)-K(+)-ATPase inhibitor characterized in two-sided liposomes containing pure renal Na(+)-K(+)-ATPase.
    Anner BM; Rey HG; Moosmayer M; Meszoely I; Haupert GT
    Am J Physiol; 1990 Jan; 258(1 Pt 2):F144-53. PubMed ID: 2154124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.